← Back to Search

Temporary changes in an already-implanted medical device (biventricular pacemaker) for Left Ventricular Assist Device Infection

N/A

Waitlist Available

Led By Uma Srivatsa, MD

Research Sponsored by University of California, Davis

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 2-5 minutes

Awards & highlights

No Placebo-Only Group

Summary

This trial is examining whether or not different settings on a pacemaker can affect the function of an LVAD.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 2-5 minutes

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~2-5 minutes

This trial's timeline: 3 weeks for screening, Varies for treatment, and 2-5 minutes for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

LVAD flow

LVAD power

LVAD pulsatility index (PI)

+1 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups

Experimental Treatment

Group I: CohortExperimental Treatment1 Intervention

Pacemakers will be programmed to BiV pacing, left ventricular (LV) pacing, right ventricular (RV) pacing and no pacing for five minutes each. LVAD flow will be recorded every thirty seconds for five minutes with each setting. Once the interventions have been completed, all pacemakers will be returned to their original setting.

Do I qualify?Apply below to find out